Beijing Deli Furui Pharmaceutical Technology

Beijing Deli Furui Pharmaceutical Technology is a specialty pharmaceutical company based in China, dedicated to the research, development, and industrialization of high-end inhalation preparations. The company focuses on respiratory diseases, particularly asthma and chronic obstructive pulmonary disease (COPD), utilizing its proprietary dry powder inhalation (DPI) technology platform. Its pipeline features complex generics and improved new drugs, including combinations of corticosteroids and long-acting beta-agonists. By mastering the core technologies of formulation and device integration, Deli Furui aims to provide high-quality alternatives to international blockbuster products in the Chinese respiratory market. The company operates a modern R&D center and manufacturing facility in Beijing to support its clinical and commercial objectives.